Serina Therapeutics Inc.

NYSE: SER · Real-Time Price · USD
5.28
-0.22 (-4.00%)
At close: Aug 15, 2025, 3:59 PM
5.20
-1.52%
After-hours: Aug 15, 2025, 07:49 PM EDT

Serina Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
6.04M 4.27M 3.67M 3.19M 6.06M 8.71M 345K 397K 8.72M 280K 645K 466K 702K 448K 584K 731K 615K 809K
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 50K 50K 50K 10.6M 10.43M 10.25M 10.08M 50K 50K 50K 50K 50K n/a 50K n/a
Other Long-Term Assets
n/a n/a n/a 333K n/a 50K -1.35M n/a -10.25M 705K 428.53K 771K 804K 837K 870K 952K 935K 50K
Receivables
n/a n/a n/a 14K 51K 65K 57K 71K n/a 6K n/a 1K 12K n/a 25K 24K 11K 48K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a -1.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
1.95M 150K 77K 143K 2K 166K 352K 673K n/a 1.46M n/a 720K 1.01M 1.38M 1.63M 720K 930K 1.28M
Total Current Assets
7.99M 5.75M 5.68M 5.42M 8.92M 8.94M 754K 1.14M 8.74M 1.75M 2.45M 1.19M 1.73M 1.83M 2.23M 1.48M 1.56M 2.14M
Property-Plant & Equipment
950K 977K 1.05M 1.12M 1.2M 1.29M 1.35M n/a 1M n/a 309.47K n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a 509K 541K 574K 607K 640K n/a n/a n/a n/a n/a n/a n/a n/a n/a 968K
Total Long-Term Assets
950K 977K 1.05M 2.01M 1.79M 1.92M 11.21M 11.07M 1M 10.78M 788K 821K 854K 887K 920K 952K 985K 1.02M
Total Assets
8.94M 6.73M 6.72M 7.43M 10.71M 10.86M 11.96M 12.21M 9.74M 12.53M 3.24M 2.01M 2.58M 2.72M 3.15M 2.43M 2.54M 3.16M
Account Payables
1.71M 1.19M 744K 1.7M 1.2M 2.6M 580K 1.17M 360.25K 707K 143.34K 351K 161K 501K 193K 184K 483K 370K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a 116.5K n/a 153.5K n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a 10.46M 10.66M 9.98M 3.67M 1.53M 7.61M 20.04M 7.65M 7.3M 6.97M 6.66M 7.14M 5.6M 3.56M 2.02M
Other Current Liabilities
3.56M 595K 1.06M 1M 114K -51K 1.08M 506K n/a 1.78M 3.99M 1.16M 1.96M 2.94M 1.63M 814K 1.23M 1.33M
Total Current Liabilities
3.56M 2.35M 2.37M 13.51M 12.63M 14.06M 5.91M 3.2M 8.58M 22.52M 10.08M 8.81M 9.09M 10.1M 8.97M 6.6M 5.27M 3.93M
Long-Term Debt
185K n/a n/a 693K 693K 693K 693K 693K n/a 10.01M 1.62M 8.35M 6.76M 4.21M 6.06M 5.81M 5.56M 5.33M
Other Long-Term Liabilities
3.55M 2.59M 3.58M 6.74M 13.41M n/a n/a n/a 36.05M n/a 8.8M n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
3.73M 2.82M 3.85M 7.75M 14.47M 1.11M 693K 693K 36.44M 10.01M 10.48M 8.35M 6.76M 4.21M 6.06M 5.81M 5.56M 5.33M
Total Liabilities
7.29M 5.17M 6.22M 21.26M 27.1M 15.16M 6.61M 3.9M 45.03M 32.54M 20.56M 17.16M 15.84M 14.31M 15.03M 12.4M 10.84M 9.26M
Total Debt
185K 227K 268K 11.47M 11.71M 11.08M 4.37M 2.22M 8.19M 30.05M 18.12M 15.65M 13.72M 10.87M 13.2M 11.41M 9.12M 7.35M
Common Stock
1K 1K 1K 1K 1K 1K n/a 4K 22.34K 4K 4K 4K 4K 4K 4K 4K 4K 4K
Retained Earnings
-55.58M -49.13M -44.32M -21.77M -23.18M -5.43M -33.18M -127.56M -35.98M -119.49M -116.21M -113.51M -111.07M -108.45M -105.75M -103.59M -101.64M -99.16M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a -4K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
1.8M 1.7M 641K -13.77M -16.36M -4.31M 4.11M 8.42M -35.29M -19.89M -17.21M -15.1M -13.22M -11.55M -11.83M -9.94M -8.25M -6.06M
Total Investments
n/a n/a n/a 50K 50K 50K 10.6M 10.43M 10.25M 10.08M 50K 50K 50K 50K 50K n/a 50K n/a